(Q77114702)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10169397%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

title

A cost-utility analysis of second-line chemotherapy in metastatic breast cancer. Docetaxel versus paclitaxel versus vinorelbine (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10169397%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

1 reference

1 reference

1 reference

R Launois

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10169397%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

J Reboul-Marty

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10169397%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

B Henry

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10169397%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

J Bonneterre

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10169397%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

publication date

1 November 1996

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10169397%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10169397%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

volume

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10169397%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10169397%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

page(s)

504-521

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10169397%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.2165/00019053-199610050-00008

3 December 2019

exact match

0 references

cites work

The use of female spouse proxies in common symptom reporting

1 reference

12 December 2020

Phase II trial of docetaxel in advanced anthracycline-resistant or anthracenedione-resistant breast cancer.

1 reference

12 December 2020

Efficacy and cost effectiveness of adjuvant chemotherapy in women with node-negative breast cancer. A decision-analysis model

1 reference

12 December 2020

Efficacy and cost-effectiveness of cancer treatment: rational allocation of resources based on decision analysis.

1 reference

12 December 2020

Phase II trial of docetaxel: a new, highly effective antineoplastic agent in the management of patients with anthracycline-resistant metastatic breast cancer

1 reference

12 December 2020

Efficacy and cost-effectiveness of autologous bone marrow transplantation in metastatic breast cancer. Estimates using decision analysis while awaiting clinical trial results

1 reference

12 December 2020

High-dose chemotherapy with autologous bone marrow transplantation for the treatment of metastatic breast cancer

1 reference

12 December 2020

A phase II trial with docetaxel (Taxotere) in second line treatment with chemotherapy for advanced breast cancer. A study of the EORTC Early Clinical Trials Group.

1 reference

12 December 2020

Determining transition probabilities: confusion and suggestions

1 reference

12 December 2020

Multicenter, randomized comparative study of two doses of paclitaxel in patients with metastatic breast cancer

1 reference

12 December 2020

A comprehensive multiattribute system for classifying the health status of survivors of childhood cancer

1 reference

12 December 2020

Vinorelbine (navelbine) as a salvage treatment for advanced breast cancer

1 reference

12 December 2020

A model of chemotherapy in node-negative breast cancer

1 reference

12 December 2020

Phase II trial of paclitaxel by 3-hour infusion as initial and salvage chemotherapy for metastatic breast cancer

1 reference

12 December 2020

Multi-attribute health status classification systems. Health Utilities Index

1 reference

12 December 2020

Markov models in medical decision making: a practical guide.

1 reference

12 December 2020

Reporting results of cancer treatment

1 reference

12 December 2020

The Markov process in medical prognosis.

1 reference

12 December 2020

Patient-proxy response comparability on measures of patient health and functional status.

1 reference

12 December 2020

Value of utility measures: recurrent respiratory infections

1 reference

12 December 2020

A convenient approximation of life expectancy (the "DEALE"). II. Use in medical decision-making.

1 reference

12 December 2020